Simple Rules Defining the Potential of Compounds for Transdermal Delivery or Toxicity

Author： Magnusson Beatrice M.   Pugh W. John   Roberts Michael S.  

Publisher： Springer Publishing Company

ISSN： 0724-8741

Source： Pharmaceutical Research, Vol.21, Iss.6, 2004-06, pp. : 1047-1054

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential of Transdermal Drug Delivery in Parkinson's Disease

By Pfeiffer R.F.  

Drugs & Aging, Vol. 19, Iss. 8, 2002-01 ,pp. : 561-570

Adis International

Access to resources Recommend Favorite

Transdermal Lipid Nanocarriers: A Potential Delivery System for Lornoxicam

By  

Pharmaceutical Nanotechnology, Vol. 5, Iss. 1, 2017-03 ,pp. : 32-43

Bentham Science Publishers

Access to resources Recommend Favorite

Potential of Peptide-Based Enhancers for Transdermal Delivery

By  

Current Pharmaceutical Design, Vol. 21, Iss. 20, 2015-06 ,pp. : 2814-2822

Bentham Science Publishers

Access to resources Recommend Favorite

Transdermal menopausal hormone therapy: delivery through skin changes the rules

By Buster John E  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 9, 2010-06 ,pp. : 1489-1499

Informa Healthcare

Access to resources Recommend Favorite

Decreasing Systemic Toxicity Via Transdermal Delivery of Anticancer Drugs

By  

Current Drug Metabolism, Vol. 9, Iss. 7, 2008-09 ,pp. : 592-597

Bentham Science Publishers

Access to resources Recommend Favorite